Jaber H, khalaf AA, Weiss L, Cohen I, Bannoura N, Osaili T, Maximov O, Chaouat AE, Kournos M, Tabib A, Mevorach D, Engel Y, Berger M, Mandelboim O, Elias S. Irradiated CD19 chimeric antigen receptor YTS cells retain antitumor activity and offer a scalable alternative to autologous CAR-T therapy. haematol [Internet]. 2020Sep.10 [cited 2026Oct.13];. Available from: https://haematologica.org/article/view/14333